H.I.G. Capital Explores Sale of Controlling Stake in Rising Pharmaceuticals

Private equity firm H.I.G. Capital is evaluating options for its majority ownership in US-based Rising Pharma, including a potential full sale of the drugmaker.

1 Sept, 08:29 — 1 Sept, 08:29

Post Share

Sources

Showing 1 of 1 sources

bloombergHigh1d ago

H.I.G. Is Said to Consider Sale of $1 Billion Drugmaker Rising Pharma

H.I.G. Capital is exploring options for its controlling stake in US-based Rising Pharmaceuticals, including a possible sale, according to people familiar with the matter.

By Baiju Kalesh and Ranjani Raghavan

Read full article →

H.I.G. Capital Explores Sale of Controlling Stake in Rising Pharmaceuticals

Sources

H.I.G. Is Said to Consider Sale of $1 Billion Drugmaker Rising Pharma

Related Stories

US and Iran Escalate Military Strikes Following Wedding Airstrike

Chevron to spend $7B-plus over five years to double Venezuelan production

Ryanair Cuts Winter Flight Capacity Amid Soaring Fuel Costs

Dyson Launches AI-Powered Smart Toothbrush With Internal Camera